Echo | Angio | ECG | X-Ray/MRI | Clinical Trials | Guidelines | Drug Info |  Journals  | Events | Interesting Cases

Welcome Nov 28, 2014
Search News by Date
 N E W S C E N T E R
Updated:  Nov 28, 2014
Impact of 1-year diet and exercise intervention on adipose tissue depots and metabolic markers in overweight and obese T2DM patients
Adipose tissue depots reductions are associated with improvements in biomarkers.
Impact of low serum total bilirubin levels on risk of CAD in patients with metabolic syndrome
Upon adding low serum bilirubin levels to the traditional risk factors for CAD, such as metabolic syndrome, risk prediction may improve.
Impact of Pistachio consumption on inflammation, and related metabolic risk markers
Pistachios consumption promotes a healthier metabolic profile.
JUPITER: Safety profile of subjects treated with rosuvastatin 20 mg daily achieving very low low-density lipoprotein cholesterol levels (<30 mg/dl)
The rate of adverse events in those with LDL-C <30 mg/dl on a statin is low.
Acute Catheterization and Urgent Intervention Triage Strategy Trial: Prognostic value of angiographic lesion complexity in ACS patients undergoing PCI
There exists an adverse short-term prognosis in patients with ACS with type C lesion characteristics undergoing PCI.
In-hospital outcomes with Drug-Eluting Stents versus Bare-Metal Stents
When compared with BMS, DES use is associated with lesser in-hospital mortality.
Impact of prasugrel + aspirin therapy on ischemic events for the TAXUS Liberté PES patient subset from DAPT due to reductions in MI and ST
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after taxus liberté paclitaxel-eluting coronary stent placement.
Edinburgh Type 2 Diabetes Study: Correlation between severe hypoglycemia, adverse macrovascular events and inflammation
There are higher odds of suffering a macrovascular event in T2DM patients, with a history of severe hypoglycemia.
Systolic pulmonary arterial pressure in HIV-positive patients
Significant increase of pulmonary hypertension in asymptomatic HIV-positive patients have no association with any other risk factor.
Left ventricular diastolic disfunction progression in patients with type 2 diabetes
The condition improves or remains stable over a period of 6 years in majority of the investigated patients with left ventricular diastolic dysfunction.
EYESHOT Study: Contemporary antithrombotic strategies in ACS patients admitted to cardiac care units
Age ≥75 years is strongly associated with the use of clopidogrel.
ATRIA-CVRN Study: Correlation between digoxin and risk of death in adults with atrial fibrillation
Digoxin use is independently associated with higher risks of death and hospitalization in adults with atrial fibrillation.
Effects of metformin and glipizide in T2DM patients with coronary artery disease
There is a clearly increased trend of triacylglycerols of a relatively higher carbon number with metformin treatment versus glipizide group.
Outcomes of aerobic interval training in comparison with moderate continuous training in patients with significant CAD receiving optimal medical treatment.
Regular aerobic exercise + optimal medical treatment induce a moderate regression of necrotic core and plaque burden in IVUS-defined coronary lesions.
Perfusion defect size in patients who underwent serial rubidium-82 positron emission tomography myocardial perfusion imaging
Changes in mild perfusion defects may provide valuable secondary information for evaluation of treatment efficacy in patients who underwent serial MPI.
Comparison of MGuard embolic protection stent with conventional stents in ST-Segment Elevation Myocardial Infarction
MGuard embolic protection stent is associated with superior rates of complete STR, even in patients with longer delays to reperfusion, in comparison with conventional metallic stents.
The Oregon Sudden Unexpected Death Study: Risk stratification for sudden cardiac death
Severe left ventricular dilatation additively increases risk of sudden cardiac death.
Outcomes of mechanical circulatory support in diabetic patients who underwent left ventricular assist devices implantation
Mechanical circulatory support improves diabetic control in advanced heart failure patients.
Effect of transradial access on mortality in patients with non–ST-segment–elevation myocardial infarction
Radial versus femoral access results in reduced complications and mortality in the patient population.
Role of modifiable cardiovascular disease risk factors on mortality risk in high-risk individuals based on CAC
Vascular calcified plaque scores are associated with increased risk for mortality.
Outcomes of amiodarone in patients with atrial fibrillation
Amiodarone + warfarin is associated with significantly increased stroke and systemic embolism risk and a lower time in the therapeutic range.
ACS patients undergoing PCI spent more time in the low acceleration category indicating sedentary behaviour and sleep than stable angina patients
Predictive role of carotid vascular strain in treated hypertension
Decreased carotid strain and strain rate are associated with cardiovascular events in regularly treated hypertensive patients.
Risk prediction by stress myocardial perfusion positron emission tomography in subjects with and without diabetes
Positron emission tomography myocardial perfusion imaging provides incremental risk prediction of cardiac death in both diabetic and non-diabetic subjects.
JPAD Trial: New blood pressure control target for diabetic patients
140/90 mmHg is a significantly better BP control target for diabetics.
Correlation between glycosylated hemoglobin level with severity of atherosclerotic cardiovascular diseases
Increased HbA1c level is independently associated with the severity of coronary artery diseases.
EXAMINE: Impact of alogliptin on NT-pro-BNP in a post-ACS T2D population
N-Terminal-pro-brain natriuretic peptide decreases following treatment with alogliptin in T2DM patients with recent acute coronary syndromes.
Pooled PROTECT Trials: Mortality risks associated with stent thrombosis with coronary stents
Early and late stent thrombosis are associated with long-term cardiac mortality.
Optimal treatment option for in-stent restenosis
Drug-eluting balloon or Drug-eluting stent markedly better prevented target lesion revascularization than plain old balloon angioplasty, but not MI or mortality in treatment of ISR.
Drug-Eluting Stents versus Bare Metal Stents outcomes in STEMI patients
Compared with BMS, DES use is associated with a significantly lower 30-day mortality, after which there is no difference in mortality between the groups.
Combination of depression and diabetes is associated with short-term risk of death and myocardial infarction among patients undergoing angiography for acute coronary syndrome
Association of endothelial dysfunction, arterial stiffness and inflammation with visual impairment among diabetics
Visual impairment could be predicted by both endothelial function and arterial stiffness with high sensitivity.
Impact of ranolazine in patients with chronic stable angina and diabetes
Ranolazine improves cardiovascular-and diabetes-related healthcare utilization in patients with chronic stable angina and co-morbid diabetes.
Benefits with delayed versus immediate stenting in AMI patients
Delayed stenting improves angiographic outcomes when compared with immediate stenting for acute myocardial infarction.
Protective affect of anticoagulation in transcutaneous aortic valve replacement
There is a trend towards improved survival and stroke rates in anticoagulation patients.
Effect of lesion morphology and location in patient with intermediate stenotic coronary lesions
Lesion location and degree of diameter stenosis affect fractional flow reserve.
Benefits of angiotensin converting enzyme inhibitors in systolic heart failure patients with glomerular filtration rate <30 ml/min/1.73 m2
ACEIs treatment is associated with improved survival in CKD patients with GFR < 30ml/min/1.73m2.
Role of digoxin in modern treatment of heart failure with sinus rhythm
Digoxin is associated with an increased risk of death in chronic HF with sinus rhythm.
ASCEND-HF: Torsemide versus Furosemide in Acute Heart Failure Patients
Minority of patients received torsemide and commonly had indicators of higher risk.
Net atrioventricular compliance: A novel parameter to predict long-term cardiac mortality in mitral stenosis
New Onset Atrial Fibrillation after First-ever Ischemic Stroke in Lund Stroke Register
Prolonged P-wave duration is the strongest predictor of AF incidence in stroke-free population.
Aspirin + Clopidogrel Therapy versus clopidogrel alone following coronary stent implantation in AMI patients
Clopidogrel alone use following coronary stenting does not increase mortality and worsen clinical outcomes when compared to DAP therapy in AMI patients.
ALKK-Registry: Optimal antithrombotic therapy in patients undergoing primary PCI
Gp IIb/IIIa inhibitors improve outcome in patients with primary PCI for STEMI treated with heparin.
Cardiovascular risk during young adulthood in offspring of women with hypertension during pregnancy
Maternal hypertension in pregnancy is associated with increased blood pressure.
CARDIA Study: Nocturnal Blood Pressure in Young Adults and Cognitive Function in Midlife
Less nocturnal SBP dipping and higher nocturnal DBP levels are associated with lower executive function in midlife in healthy young adults.
CARDIA Study: Impact of cumulative blood pressure in early adulthood on cardiac dysfunction during middle age
BP for over 25 years from young adulthood to middle age results in left ventricular systolic and diastolic dysfunction in middle age.
Systematic Review and Meta-Analysis: Impact of sitagliptin on cardiac outcomes
Sitagliptin versus placebo shows no significant benefit on cardiac outcomes.
Time dependent effects Dapagliflozin on cardiovascular safety
Dapagliflozin was not associated with any increased risk of early or late adjudicated cardiovascular events.
BP lowering effect of Empagliflozin in T2DM patients under background antihypertensive treatment
BP reduction with empagliflozin in type 2 diabetes is similar in treatment naïve as in those on one or ≥ 2 antihypertensive agents.
Long-term outcome of acute myocardial infarction with initial low-density lipoprotein cholesterol reduction in the statin era
Impact of exercise training on Ang-II and AGEs in patients with diabetic kidney disease
Exercise reduces angiotensin II and advanced glycation end products in patients with diabetic kidney disease.
Decompensated heart failure
Resistant Hypertension: A challenge for primary care clinicians and specialists
Safety outcomes of aortic valve replacement in aortic stenosis
Fixed-Drug Combinations for an Effective, Treatment Adherence led BP control
Biodegradable Stents or Scaffolds over DESs
Controversies in the significance of Fractional Flow Reserve Measurement for the Assessment of Coronary Artery Disease
Making a Wise Choice for Enhancing the Success of an unstable PCI Era
Risk Management and New Technologies in Atrial Fibrillation Ablation as the First-line therapy for a Lasting Cure
Chronic Kidney Disease as a New Therapeutic Target in the DES, Valvular and STEMI Era
Prognosis of Hypertrophic Cardiomyopathy
Newer oral anticoagulation therapy for patients with atrial fibrillation
A Coronary Perforation Complicating a PCI is No More Feared: The Dual Catheter rather than Single Catheter Access Technique for a dauntless cardiac intervention


The WATCHMAN™ Left Atrial Appendage Closure Device receives favorable vote by FDA Advisory Committee Panel

FDA clears 150 cm Length Arrow® GPSCath® Balloon Dilatation Catheters

FDA approves Sorin Group's Solo Smart™ Aortic Pericardial Heart Valve

A 81 year old male patient with a history of hypertension, dyslipidemia, and smoking, presented with a history of chest pain with minimal efforts of two days duration.
Good angiographic result with a TIMI 3 flow was attained. The crush technique was the first choice in the treatment of complex bifurcation lesion of left main.

ACC 2015
Saturday, March 14, 2015 - Monday, March 16, 2015
San Diego.


Featured Article

Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)

About Us | Disclaimer |  Privacy Statement | Advertising Info © Copyright 2000-2014 Centrix Healthcare Inc. - All Rights Reserved.